In our day to day practice we find that majority of the patients suffer from respiratory diseases, of which Pulmonary Koch's is the first and foremost. It is being completely curable doesn't affect the quality of life so much as the Bronchial asthma. Ayurvedic medicines provide a wide range of formulations & treatment modalities for the management of this chronic disease. Hence a controlled study was carried out to evaluate the efficacy and safety of Nidigdhikadi Kvatha, an Ayurvedic formulation in bronchial asthma vis-a-vis Tamaka shvasa. In this study 40 patients of Tamaka shvasa in Avegavastha (remission stage) were registered, out of which 20 patients were included in trial group and treated with Nidigdhikadi kvatha & another 20 patients were included in control group and treated with Tablet of Deriphylline-retard by simple random sampling method. In both the groups the effect of drugs on symptoms of Tamaka shvasa was significant; however it was observed that, trial drug formulation proved to be effective in relieving symptoms like Kasa (coughing) and Kashtena shleshma moksha (difficult expectoration) than control drug. The effect of drugs on respiratory rate was more in trial group than control group. There was a decrease in the eosinophil and neutrophil count which was significant (p < 0.001).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.